NRX Pharmaceuticals Inc. Gains 45.71%
Mon, May 06, 2024 at 07:19 PM
NRX Pharmaceuticals Inc. (NRXP:NASDAQ) rocketted at $3.06, representing a gain of 45.7%. On Mon, May 06, 2024, NRXP:NASDAQ touched a New 2-Week Intraday High of $3.75. The stock appeared on our News Catalysts scanner on Mon, May 06, 2024 at 11:46 AM in the 'BIOTECH' category. From Mon, Apr 22, 2024, the stock recorded 70.00% Up Days and 54.55% Green Days
The stock spiked on Tue, Mar 05, 2024 at $7.33 with a volume of 1M+.
About NRX Pharmaceuticals Inc. (NRXP:NASDAQ)
NRX Pharmaceuticals Inc is a clinical-stage, small molecule pharmaceutical company which develops novel therapeutics for the treatment of central nervous system disorders and life-threatening...
Top 10 Gainers:
- Holdco Nuvo Group D.G Ltd. (NUVO:NASDAQ), 157.35%
- Strong Global Entertainment Inc. Class A Common (SGE:NYSEMKT), 132.44%
- XBP Europe Holdings Inc. (XBP:NASDAQ), 65.09%
- Plutonian Acquisition Corp. (PLTN:NASDAQ), 57.07%
- Perficient, Inc. (PRFT:NASDAQ), 52.28%
- Movella Holdings Inc Com (MVLA:NASDAQ), 50.5%
- Kubient Inc. (KBNT:NASDAQ), 50%
- Viveve Medical, Inc. (VIVE:NASDAQ), 50%
- SRAX, Inc. (SRAX:NASDAQ), 50%
- NRX Pharmaceuticals Inc. (NRXP:NASDAQ), 45.71%